Drug intelligence / Profile preview

chromium nicotinate

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Chromium nicotinate is a small molecule compound used primarily as a dietary supplement to treat or prevent chromium deficiency and for nutritional support in patients who cannot eat normally. It is also known as "chromium polynicotinate" or "niacin-bound chromium," and consists of trivalent chromium (Cr3+) bound to three molecules of nicotinic acid. Chromium is an essential trace mineral involved in the regulation of glucose metabolism and insulin sensitivity. Its mechanism involves potentiating insulin signaling by enhancing the activity of the insulin receptor and downstream effectors such as PI3K and Akt, leading to increased translocation of GLUT-4 transporters to the cell membrane and improved glucose uptake in muscle cells. Chromium supplementation has been studied for use in conditions associated with diabetes mellitus type 2[1][2][5].

Brand names
ChromeMate
Other names
chromium polynicotinateniacin-bound chromium
02

Targets

PTPN1 (Protein tyrosine phosphatase 1B)SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)INSR (Insulin receptor)

Beyond the preview

Go deeper on chromium nicotinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chromium nicotinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call